{
    "organizations": [],
    "uuid": "d28f05ddca454431f3271a06057ee28823e657a2",
    "author": "",
    "url": "https://www.reuters.com/article/brief-galapagos-announces-isabela-phase/brief-galapagos-announces-isabela-phase-3-program-in-ipf-idUSFWN1RP0X1",
    "ord_in_thread": 0,
    "title": "BRIEF-Galapagos Announces Isabela Phase 3 Program In IPF",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12, 2018 / 8:06 PM / Updated 4 minutes ago BRIEF-Galapagos Announces Isabela Phase 3 Program In IPF Reuters Staff \nApril 12 (Reuters) - Galapagos NV: * GALAPAGOS ANNOUNCES ISABELA PHASE 3 PROGRAM IN IPF \n* ANNOUNCES DESIGN OF A WORLDWIDE PHASE 3 PROGRAM TO EVALUATE GLPG1690 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS \n* GLOBAL PHASE 3 PROGRAM IS EXPECTED TO CONSIST OF TWO IDENTICALLY DESIGNED TRIALS, ISABELA 1 AND ISABELA 2 \n* PHASE 3 PROGRAM IS EXPECTED TO START DOSING IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-04-12T23:05:00.000+03:00",
    "crawled": "2018-04-12T23:12:57.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "isabela",
        "phase",
        "program",
        "ipf",
        "reuters",
        "staff",
        "april",
        "reuters",
        "galapagos",
        "nv",
        "galapagos",
        "announces",
        "isabela",
        "phase",
        "program",
        "ipf",
        "announces",
        "design",
        "worldwide",
        "phase",
        "program",
        "evaluate",
        "glpg1690",
        "patient",
        "idiopathic",
        "pulmonary",
        "fibrosis",
        "global",
        "phase",
        "program",
        "expected",
        "consist",
        "two",
        "identically",
        "designed",
        "trial",
        "isabela",
        "isabela",
        "phase",
        "program",
        "expected",
        "start",
        "dosing",
        "second",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}